Illinois Department of Healthcare and Family Services Drugs and Therapeutics Advisory Board met July 13.
Here is the agenda provided by the board:
I. Call to Order
II. Roll Call
III. Announcements
IV. Agenda and Conflict of Interest Review
V. Approval of the Minutes
VI. Public Comments
VII. PDL Drug Appeals
a. None at this meeting
VIII. New Drug Appeals
a. None at this Meeting
IX. Drug Class Review- Jen Phillips, PharmD clinical review (with discussion and vote)
a. Sickle Cell Disease
X. New Drug Initial Review-Jen Phillips, PharmD clinical review(with discussion and vote)
a. Auvi-Q
b. Orserdu
c. Carbaglu
XI. Future Agenda Preview -Sheri Dolan
XII. Provider Requested Reviews-Sheri Dolan
XIII. Department Update-Jose Jimenez
XIV. Adjournment
https://hfs.illinois.gov/content/dam/soi/en/web/hfs/sitecollectiondocuments/DTAdvisoryBoardAgenda07132023.pdf
Alerts Sign-up